Skip to main content
HeartCited

Potassium 관련 고혈압

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

WHO conditional recommendation. Meta-analysis: systolic -3.49 mmHg. DASH diet (4,700 mg K/day) reduces systolic BP by 8-14 mmHg. Potassium-enriched salt substitutes reduced stroke risk by 14% in a 2022 Lancet study.

B

결론

WHO conditional recommendation. Meta-analysis: systolic -3.49 mmHg. DASH diet (4,700 mg K/day) reduces systolic BP by 8-14 mmHg. Potassium-enriched salt substitutes reduced stroke risk by 14% in a 2022 Lancet study.

Key Study Findings

Case Reports n=1
Pseudo-Hyperaldosteronism Arising from Licorice Cough Syrup Self-Ingestion: A Case Report.
Dose: Licorice cough syrup (glycyrrhiza glabra) Outcome: Hypokalemia, hypertension, metabolic alkalosis

대상 집단: Single patient with licorice intoxication

Case Reports 13.0 weeks
A case report of Gitelman syndrome in children.
Dose: 3 g Outcome: pain reduction

대상 집단: Hypokalemia

Meta-Analysis n=1258
Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials.
Dose: 25 mg/day (typical) vs: Placebo or standard care Outcome: All-cause mortality 효과: RR=0.42, P<0.0001 P<0.0001

대상 집단: Dialysis-dependent ESRD patients

Other 8 weeks
Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and Induction of Oxidative …
Dose: 150 g Outcome: whether the rats were acidotic, blood pH was …
Review
Clinically Relevant Drug-Drug Interactions in Primary Care.
Dose: 20 mg
Observational Study n=40
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Dose: anti-digoxin antibodies (Fab) vs: pre-treatment Outcome: serum digoxin and clinical outcomes 효과: Fab bound digoxin; no improved clinical outcomes

대상 집단: Chronic digoxin toxicity patients

Key Statistics

22

연구

1600

참여자

↑

Positive

B

등급

Referenced Papers

Pseudo-Hyperaldosteronism Arising from Licorice Cough Syrup Self-Ingestion: A Case Report. Case Report
Reports (MDPI) 2024 1 인용
A case report of Gitelman syndrome in children. Case Report
Medicine 2023
Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials. Systematic Review
Frontiers in medicine 2022 9 인용
Hypokalemia-induced rhabdomyolysis as the first symptom of primary aldosteronism: a case report and literature review. Case Report
Annals of palliative … 2022 6 인용
Bilateral Adrenalectomy in a Patient With Refractory Primary Aldosteronism Due to Adrenal Hyperplasia. Case Report
Cureus 2022 1 인용
Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and Induction of Oxidative Stress. Other
Antioxidants (Basel, Switzerland) 2020 10 인용
Prevalence of primary aldosteronism in hypertensive kidney transplant recipients: A cross-sectional study. Other
Clinical transplantation 2020 4 인용
Clinically Relevant Drug-Drug Interactions in Primary Care. Review
American family physician 2019 49 인용
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Observational
Clinical toxicology (Philadelphia, … 2016 25 인용
A Woman with Normotensive Primary Hyperaldosteronism. Case Report
Acta medica Iranica 2016 10 인용
Minoxidil use in dermatology, side effects and recent patents. Review
Recent patents on … 2012
Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Other
Pharmacoepidemiology and drug … 2011 26 인용
Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Other
Dermatologic clinics 2010 80 인용
Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. Other
Journal of internal … 2005 197 인용
Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma. Case Report
American journal of … 2001 51 인용
Prevention of hypokalemia caused by diuretics. Review
Heart disease and … 1994
Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial … RCT
European journal of … 1986 22 인용
High dose furosemide in refractory cardiac failure. Other
European heart journal 1985 23 인용
New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme). Other
Drug intelligence & … 1981 7 인용
Hypokalemia during the treatment of arterial hypertension with diuretics. Other
Canadian Medical Association … 1980
Potassium metabolism in patients with rheumatoid arthritis. Effects of treatment with depot tetracosactrin, spironolactone, and oral supplements of potassium chloride. Other
Annals of the … 1975 5 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

supplements:
Typically 99 mg/dose (FDA limit per unit)
dashdiettarget:
4,700 mg/day
whorecommendation:
3,510 mg/day from food

상한량: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

연구에서 사용된 용량

용량 기간 효과 N
Licorice cough syrup (glycyrrhiza glabra) -- Negative 1
3 g 13.0 weeks Mixed --
25 mg/day (typical) -- Positive 1258
150 g 8 weeks Neutral --
20 mg -- Positive --
anti-digoxin antibodies (Fab) -- Neutral 40
6.5 mmol/l 52.0 weeks Mixed --
100 mg/d 26.0 weeks Mixed 48

권장 복용 시간: With meals to reduce GI irritation; divide supplemental doses throughout the day

Safety & Side Effects

보고된 부작용

  • ⚠ Gastrointestinal irritation (nausea, vomiting, diarrhea)
  • ⚠ Hyperkalemia risk in patients with renal impairment
  • ⚠ Cardiac arrhythmias at excessively high serum levels

알려진 상호작용

  • ● ACE inhibitors (increased hyperkalemia risk)
  • ● ARBs (increased hyperkalemia risk)
  • ● Potassium-sparing diuretics (increased hyperkalemia risk)
  • ● NSAIDs (may increase potassium retention)

일일 최대 섭취 허용량: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Potassium help with 고혈압?
Based on 22 studies with 1,600 participants, there is moderate evidence from clinical studies that Potassium may support 고혈압 management. Our evidence grade is B (Good Evidence).
How much Potassium should I take for 고혈압?
Studies have used various dosages. A commonly studied range is Typically 99 mg/dose (FDA limit per unit). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Potassium?
Reported side effects may include Gastrointestinal irritation (nausea, vomiting, diarrhea), Hyperkalemia risk in patients with renal impairment, Cardiac arrhythmias at excessively high serum levels. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Potassium and 고혈압?
We rate the evidence as Grade B (Good Evidence). This rating is based on 22 peer-reviewed studies with 1,600 total participants. The overall direction of effect is positive.

Potassium 다른 건강 상태에 대한 근거

부정맥 C

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  










  
References

  
    
    
    
  1. 
      [1]
      Chien-Chun Liao et al..
      Reports (MDPI).
      2024.
      Pseudo-Hyperaldosteronism Arising from Licorice Cough Syrup Self-Ingestion: A Case Report.
      doi:10.3390/reports7040085
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Jing Ying et al..
      Medicine (Baltimore).
      2023.
      A case report of Gitelman syndrome in children.
      doi:10.1097/MD.0000000000033509
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Jing Liu et al..
      Front Med (Lausanne).
      2022.
      Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials.
      doi:10.3389/fmed.2022.828189
      PubMed
    
    4. 
    
    
  4. 
      [4]
      Rongfeng Han et al..
      Ann Palliat Med.
      2022.
      Hypokalemia-induced rhabdomyolysis as the first symptom of primary aldosteronism: a case report and literature review.
      doi:10.21037/apm-21-3010
      PubMed
    
    5. 
    
    
  5. 
      [5]
      Luis Marín-Martínez et al..
      Cureus.
      2022.
      Bilateral Adrenalectomy in a Patient With Refractory Primary Aldosteronism Due to Adrenal Hyperplasia.
      doi:10.7759/cureus.24267
      PubMed
    
    6. 
    
    
  6. 
      [6]
      Dinesh Aryal et al..
      Antioxidants (Basel).
      2020.
      Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and Induction of Oxidative Stress.
      doi:10.3390/antiox10010002
      PubMed
    
    7. 
    
    
  7. 
      [7]
      Neetika Garg et al..
      Clin Transplant.
      2020.
      Prevalence of primary aldosteronism in hypertensive kidney transplant recipients: A cross-sectional study.
      doi:10.1111/ctr.13999
      PubMed
    
    8. 
    
    
  8. 
      [8]
      Mary Carpenter et al..
      Am Fam Physician.
      2019.
      Clinically Relevant Drug-Drug Interactions in Primary Care.
      
      PubMed
    
    9. 
    
    
  9. 
      [9]
      Betty S Chan et al..
      Clin Toxicol (Phila).
      2016.
      Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
      doi:10.1080/15563650.2016.1175620
      PubMed
    
    10. 
    
    
  10. 
      [10]
      Sedighe Moradi et al..
      Acta Med Iran.
      2016.
      A Woman with Normotensive Primary Hyperaldosteronism.
      
      PubMed
    
    11. 
    
    
  11. 
      [11]
      Alfredo Rossi et al..
      Recent Pat Inflamm Allergy Drug Discov.
      2012.
      Minoxidil use in dermatology, side effects and recent patents.
      doi:10.2174/187221312800166859
      PubMed
    
    12. 
    
    
  12. 
      [12]
      Pernelle Noize et al..
      Pharmacoepidemiol Drug Saf.
      2011.
      Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals.
      doi:10.1002/pds.2128
      PubMed
    
    13. 
    
    
  13. 
      [13]
      Deepani Rathnayake et al..
      Dermatol Clin.
      2010.
      Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
      doi:10.1016/j.det.2010.03.011
      PubMed
    
    14. 
    
    
  14. 
      [14]
      Y Jammes et al..
      J Intern Med.
      2005.
      Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise.
      doi:10.1111/j.1365-2796.2005.01452.x
      PubMed
    
    15. 
    
    
  15. 
      [15]
      T Rickman et al..
      Am J Kidney Dis.
      2001.
      Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma.
      doi:10.1016/s0272-6386(01)80134-7
      PubMed
    
    16. 
    
    
  16. 
      [16]
      E Bourke et al..
      Heart Dis Stroke.
      1994.
      Prevention of hypokalemia caused by diuretics.
      
      PubMed
    
    17. 
    
    
  17. 
      [17]
      T Dyckner et al..
      Eur J Clin Pharmacol.
      1986.
      Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial …
      doi:10.1007/BF00542411
      PubMed
    
    18. 
    
    
  18. 
      [18]
      D L Kuchar et al..
      Eur Heart J.
      1985.
      High dose furosemide in refractory cardiac failure.
      doi:10.1093/oxfordjournals.eurheartj.a061793
      PubMed
    
    19. 
    
    
  19. 
      [19]
      H L Macfie et al..
      Drug Intell Clin Pharm.
      1981.
      New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme).
      doi:10.1177/106002808101500202
      PubMed
    
    20. 
    
    
  20. 
      [20]
      G Lemieux et al..
      Can Med Assoc J.
      1980.
      Hypokalemia during the treatment of arterial hypertension with diuretics.
      
      PubMed
    
    21. 
    
    
  21. 
      [21]
      G Nuki et al..
      Ann Rheum Dis.
      1975.
      Potassium metabolism in patients with rheumatoid arthritis. Effects of treatment with depot tetracosactrin, spironolactone, and oral supplements of potassium chloride.
      doi:10.1136/ard.34.6.506
      PubMed
    
    22. 
    
  















    

        FDA 면책 조항:
        이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.